Frequency and sequence of proteinuria positivity and clinical outcomes in patients with diabetes: A nationwide cohort study
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16345 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Junseok Jeon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Proteinuria, Kidney Failure, Chronic, Diabetic Nephropathies, Cardiovascular Diseases. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Ministry of Health and Welfare (South Korea).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Proteinuria is a risk factor for end‐stage kidney disease (ESKD) and cardiovascular disease (CVD) in patients with diabetes. However, the clinical implications of fluctuating proteinuria are unclear. We investigated the proteinuria burden and the risks of clinical outcomes in patients with diabetes using the Korean National Health Insurance Service database. Materials and Methods This retrospective cohort study included patients with diabetes who participated in a national health screening between 2015 and 2016, with records of three previous health screenings. Each end‐point was followed until 31 December 2022. The proteinuria burden (range: 0–4) was defined as the cumulative number of positive urine protein dipstick tests at each health screening. The outcomes included ESKD, CVD and all‐cause mortality.
Results
Among 1 264 699 patients, 86.3%, 9.4%, 2.5%, 1.2% and 0.6% had proteinuria burdens of 0 to 4, respectively. The proteinuria burden and risks of clinical outcomes had dose‐dependent associations; compared to proteinuria burden 0, the adjusted hazard ratio (95% confidence interval) of proteinuria burdens 1, 2, 3 and 4, respectively, were as follows: ESKD, 3.539 (3.326–3.766), 9.373 (8.816–9.965), 14.539 (13.652–15.484) and 19.704 (18.412–21.087); CVD, 1.247 (1.214–1.280), 1.530 (1.465–1.599), 1.815 (1.713–1.923) and 2.032 (1.883–2.192); and all‐cause mortality, 1.335 (1.302–1.369), 1.703 (1.635–1.774), 1.959 (1.855–2.068) and 2.092 (1.945–2.250). Within the same proteinuria burdens, late‐positive proteinuria was associated with worse outcomes than early‐positive proteinuria.
Conclusions
The proteinuria burden was dose‐dependently associated with clinical outcomes in patients with diabetes. Even a single positive dipstick test requires active management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea.
ORCID-Profile: Junseok Jeon, Hye Ryoun Jang
Förderung
- Ministry of Health and Welfare (South Korea)
Zitieren
APA
Jeon, J., Lee, K., Lee, J. E., Huh, W., Han, K., & Jang, H. R. (2025). Frequency and sequence of proteinuria positivity and clinical outcomes in patients with diabetes: A nationwide cohort study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16345
Vancouver
Jeon J, Lee K, Lee JE, Huh W, Han K, Jang HR. Frequency and sequence of proteinuria positivity and clinical outcomes in patients with diabetes: A nationwide cohort study. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16345
BibTeX
@article{Jeon2025,
author = {Jeon, Junseok and Lee, Kyungho and Lee, Jung Eun and Huh, Wooseong and Han, Kyungdo and Jang, Hye Ryoun},
title = {Frequency and sequence of proteinuria positivity and clinical outcomes in patients with diabetes: A nationwide cohort study},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16345}
}
EUVIMED